Results 11 to 20 of about 571 (112)

Spesolimab for treatment of generalized pustular psoriasis of pregnancy

open access: yesPregnancy
Introduction Generalized pustular psoriasis (GPP) is a severe, desquamating skin disorder associated with pregnancy that presents as fever, fatigue, malaise and sterile pustules.
Jason Bunn   +9 more
doaj   +2 more sources

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline

open access: yesJournal of Dermatological Treatment
Purpose Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis characterized by rapidly developing, painful ulcers. This study explores the potential of spesolimab, an anti-IL-36R antibody, as a therapeutic option for refractory PG.Materials and ...
Hongzhong Jin
exaly   +3 more sources

Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report

open access: yesFrontiers in Immunology
Generalized pustular psoriasis (GPP) is a rare chronic inflammatory pustular dermatosis that presents as painful erythema with sterile pustules on nonacral skin. No unified standard and guideline for the treatment of GPP has been established.
Pengfei Wen, Xian Jiang, Jiang Xian
exaly   +3 more sources

Generalized Pustular Psoriasis During Early Pregnancy Successfully Treated with Spesolimab: A Case Report [PDF]

open access: yesInternational Medical Case Reports Journal
Xinlong Chen, Degui Chang, Chenjian Tang Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of ChinaCorrespondence: Chenjian Tang, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s ...
Chen X, Chang D, Tang C
doaj   +2 more sources

Achieving Therapeutic Success with Spesolimab: Two Cases of Drug-Induced Generalized Pustular Psoriasis Initially Mimicking Acute Generalized Exanthematous Pustulosis [PDF]

open access: yesJournal of Inflammation Research
Jianxia Chen,1,* Yuting Xia,2,3,* Faqiong Zhou,1 Juan Tao,2,3 Nuoya Zhou2,3 1Department of Dermatology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, People’s Republic of China; 2Department of ...
Chen J, Xia Y, Zhou F, Tao J, Zhou N
doaj   +2 more sources

Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights [PDF]

open access: yesFrontiers in Immunology
A 62-year-old Chinese woman presented to the hospital for help with generalized pustular psoriasis (GPP) and acrodermatitis continua of Hallopeau (ACH).
Xin-Yi Hou   +7 more
doaj   +2 more sources

Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab

open access: yesJournal of Dermatological Treatment
Generalized pustular psoriasis (GPP) in pregnancy can lead to severe complications for both mother and fetus. The treatment of this disease is challenging, especially in recalcitrant and severe cases. Until present, there are no evidence-based guidelines
Ruoyu Li
exaly   +3 more sources

Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date

open access: yesPsoriasis: Targets and Therapy
Federica Rega, Federica Trovato, Giulio Bortone, Giovanni Pellacani, Antonio Giovanni Richetta, Annunziata Dattola Dermatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Science, University of La Sapienza, Rome ...
Giovanni Pellacani, Annunziata Dattola
exaly   +2 more sources

Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP). [PDF]

open access: yesJ Dermatol
ABSTRACT Generalized pustular psoriasis (GPP) is a heterogeneous, systemic neutrophilic inflammatory disease, characterized by chronic symptoms and recurrent flares, which can be potentially life‐threatening. Spesolimab, an interleukin‐36 receptor antagonist, has been approved to treat GPP flares in many countries including Japan.
Morita A   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy